Key result
Prehospital nitrates plus CPAP linked to ~85% lower 7-day mortality in acute cardiogenic pulmonary edema.
Why the study?
Vasodilators and non-invasive ventilation improve outcomes for acute cardiogenic pulmonary oedema in the emergency department, raising the possibility that initiating both therapies in the prehospital setting could similarly improve outcomes.
Cohort (n=1,749)
No
Answers are grounded in this paper and cite their sources.
Should not yet change prehospital practice in acute cardiogenic pulmonary oedema; hypothesis-generating association requires randomized confirmation.
Background Acute heart failure is a common presentation to Emergency Departments (ED) the world over. Amongst the most common presenting signs and symptoms is dyspnoea due to acute pulmonary oedema, a life-threatening emergency that if left untreated or poorly managed. There is increasing evidence demonstrating improved outcomes following the use of vasodilators or non-invasive ventilation for these patients in the emergency setting. Consequently, the potential exists that initiating these therapies in the prehospital setting will similarly improve outcomes. Methods A historical cohort study was conducted to assess the effect of a prehospital initiated treatment protocol of nitrates plus non-invasive ventilation (NIV) versus regular therapy for severe cardiogenic APO on all-cause in-hospital mortality at 7 days, 30 days, and in total. Secondary outcomes included changes in EMS respiratory and haemodynamic parameters; admission status; length of stay; and emergency endotracheal intubation. Results The intervention led to an approximate 85% reduction in adjusted odds of mortality at 7 days compared to the regular therapy (AOR 0.15, 95% CI: 0.05 – 0.46, p = 0.001); approximate 80% reduction in odds of mortality at 30 days (AOR 0.19, 95% CI: 0.07 – 48, p < 0.0001); and Approximate 60% reduction in odds of total mortality (AOR 0.25, 95% CI: 0.12 – 0.56, p = 0.001). Conclusion The results of this analysis provide strong evidence of the potential synergistic benefits that can be achieved with the early implementation of a simple treatment protocol of prehospital administered nitrates and initiation of NIV for cardiogenic APO.
No takes yet. Share an insight, caveat, or question.
Howard et al. (2021) conducted a cohort in Acute cardiogenic pulmonary oedema (n=1,749). Prehospital protocol of sublingual Glyceryl Trinitrate (GTN) plus Continuous Positive Airway Pressure (CPAP) non-invasive ventilation vs. Regular therapy (historical discretionary care) was evaluated on All-cause in-hospital mortality at 7 days (OR 0.15, 95% CI 0.05-0.46, p=0.001). Prehospital nitrates plus CPAP reduced the adjusted odds of 7-day in-hospital mortality by 85% compared to regular therapy in acute cardiogenic pulmonary oedema.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: